TIG Advisors »

Apellis Pharmaceuticals shares owned by TIG Advisors

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by TIG Advisors from 13F filings

Historical chart of TIG Advisors investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by TIG Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by TIG Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $14M 227k 59.86

More positions owned by TIG Advisors

United States Steel Corporation Put Option (X)
Capri Holdings SHS (CPRI)
stock
ImmunoGen
Ansys Call Option (ANSS)
Endeavor Group Hldgs Cl A Com Put Option (EDR)
Pioneer Natural Resources (PXD)
Albertsons Cos Common Stock Put Option (ACI)
Cleveland-cliffs (CLF)
Chevron Corporation (CVX)
Cytokinetics Com New Call Option (CYTK)
Argenx Se Sponsored Adr Call Option (ARGX)
Apellis Pharmaceuticals (APLS)
Gracell Biotechnologies Sponsored Ads
Neurocrine Biosciences Call Option (NBIX)

View all positions for TIG Advisors

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
Jennison Associates
Octagon Capital Advisors
Jpmorgan Chase & Co
T. Rowe Price Associates
Assenagon Asset Management
Logos Global Management
Boxer Capital
Artal Group
Citadel Advisors
Caption Management
Fiera Capital Corporation

View all funds holding Apellis Pharmaceuticals